Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan

Author:

Suzuki Toru123,Aizawa Kenichi4,Shibuya Kenji5,Yamanaka Shinya67,Anzai Yuichiro57,Kurokawa Kiyoshi78,Nagai Ryozo17

Affiliation:

1. Jichi Medical University, Tochigi, Japan

2. The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

3. University of Leicester, NIHR Leicester Biomedical Research Centre, Leicester, United Kingdom

4. Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi, Japan

5. Tokyo Foundation for Policy Research, Tokyo, Japan

6. Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan

7. The Advisory Board of the COVID-19 Artificial Intelligence Simulation Project promoted by the Office for COVID-19 and Other Emerging Infectious Disease Control, Cabinet Secretariat, Government of Japan

8. Health and Global Policy Institute, Tokyo, Japan

Abstract

ImportanceReal-world evidence of SARS-CoV-2 transmission is needed to understand the prevalence of infection in the Japanese population.ObjectiveTo conduct sentinel screening of the Japanese population to determine the prevalence of SARS-CoV-2 infection in asymptomatic individuals, with complementary analysis for symptomatic patients as reported by active epidemiologic surveillance used by the government.Design, Setting, and ParticipantsThis cross-sectional study of a sentinel screening program investigated approximately 1 million asymptomatic individuals with polymerase chain reaction (PCR) testing for SARS-CoV-2 infection between February 22 and December 8, 2021. Participants included children, students, employed adults, and older individuals, as well as volunteers to broadly reflect the general Japanese population in the 14 prefectures of Japan that declared a state of emergency. Saliva samples and a cycle threshold (Ct) value of approximately 40 as standard in Japan were used. Polymerase chain reaction testing for symptomatic patients was separately done by public health authorities, and the results were obtained from the Ministry of Health, Labour, and Welfare of Japan to complement data on asymptomatic infections from the present study.Main Outcomes and MeasuresTemporal trends in positivity and prevalence (including surges of different variants) and demographic associations (eg, age, geographic location, and vaccination status) were assessed.ResultsThe positive rate of SARS-CoV-2 infection in 1 082 976 asymptomatic individuals (52.08% males; mean [SD] age 39.4 [15.7] years) was 0.03% (95% CI, 0.02%-0.05%) during periods without surges and a maximum of 0.33% (95% CI, 0.25%-0.43%) during peak surges at the Japanese standard Ct value of approximately 40; however, the positive rate would have been 10-fold less at a Ct value of 25 as used elsewhere in the world (eg, UK). There was an increase in patients with a positive PCR test result with a Ct value of 25 or 30 preceding surges in infection and hotspots of asymptomatic infections.Conclusions and RelevanceIn this cross-sectional study of asymptomatic SARS-CoV-2 infection in the general population of Japan in 2021, as investigated by sentinel surveillance, a low rate of infection was seen in the Japanese population compared with reported levels elsewhere in the world. This finding provides real-world data on the state of infection in Japan.

Publisher

American Medical Association (AMA)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3